Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Regenxbio Inc.

NASDAQ: RGNX · Life Sciences · 4 alerts · CIK 1590877

Share price
$7.32Close, Nov 16
Market cap
$484M
Shares outstanding
66.12MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Regenxbio Inc. filings on SEC EDGAR ↗

7:00 AM ET 8-K
Leadership Change

Regenxbio Leadership Change

Kenneth T. Mills resigned from the board of directors of REGENXBIO Inc. effective October 21, 2026, to focus on his new role as CEO of another company. In response, the board appointed George Migausky as the new Chairman of the Board, while Daniel Tassé stepped down as Lead Independent Director but remains on the board.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.